Lijun Sun

This inventor holds 141 USPTO granted patents and 43 published patent applications, plus 6 CIPO patents and 18 EPO patents, primarily in Immunotherapy Compounds (CPC class C07D401-14). Top assignees: Synta Pharmaceuticals Corporation, The University of Texas System, Immunesensor Therapeutics, Inc.. Active years: 1999-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lijun Sun. Retrieved from https://idiyas.com/inventor/lijun-sun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 141 (Patent Applications = 43)

% Patents Active = 53.2

CIPO Patents = 6 (Patent Applications = 12)

EPO Patents = 18 (Patent Applications = 28)

Average Co-Inventor Count = 4.1

ph-index = 24

Forward Citations = 1,368(Granted Patents)

Forward Citations (Not Self Cited) = 926(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Marietta, GA (US) (2000 - 2001)
Decatur, AL (US) (1999 - 2002)
Harvard, MA (US) (2003 - 2023)
Dallas, TX (US) (2009 - 2024)
La Canada Flintridge, CA (US) (2019 - 2024)

Company Filing History:

100 out of 162

Synta Pharmaceuticals Corporation

patents

19 out of 5,640

The University of Texas System

patents

13 out of 13

Immunesensor Therapeutics, Inc.

patents

4. 8 out of 539

Beth Israel Deaconess Medical Center, Inc.

patents

5. 2 out of 1,074

Children's Medical Center Corporation

Healthall Laboratory, Inc.

patents

8. 2 out of 5

Shionogi Bioresearch Corporation

patents

9. 1 out of 1

Eternal Sunrise Trust

patent

10. 1 out of 3

Kava Pharmaceuticals, Inc.

Shiongi Bioresearch Corp.

patent

13. 1 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2026

Loading Chart...

Areas of Expertise:

Immunotherapy

cGAS Antagonists

Superabsorbent Materials

Proliferative Diseases

Cholesterol Reduction

Mast-Cell Modulators

Aryl Hydrocarbon Receptor

Cyclic Di-Nucleotide

Paclitaxel Enhancers

Antibody-Sting Agonists

Hsp90 Activity

Inflammation Compounds

141 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12655118 - CGAS antagonist compounds (2026-06-16),

2. 12459938 - ORAI channel inhibitors (2025-11-04),

3. 12311030 - Antibody-sting agonist conjugates and their use in immunotherapy (2025-05-27),

4. 12285738 - Modulation of glucose bioaccessibility with superabsorbent materials (2025-04-29),

5. 12281078 - Quinoline cGAS antagonist compounds (2025-04-21),

6. 12152016 - Aryl hydrocarbon receptor modulators and uses thereof (2024-11-26),

7. 12134609 - Quinoline cGAS antagonist compounds (2024-11-05),

8. 12091387 - Quinoline cGAS antagonist compounds (2024-09-17),

9. 12065416 - cGAS antagonist compounds (2024-08-20),

10. 11925660 - Treatment for obesity with superabsorbent materials (2024-03-12),

11. 11918602 - Methods for reducing cholesterol with superabsorbent materials (2024-03-05),

12. 11873291 - Quinoline cGAS antagonist compounds (2024-01-16),

13. 11819527 - Superabsorbent materials and methods of making the same (2023-11-21),

14. 11697640 - Compounds for treating proliferative diseases (2023-07-11),

15. 11634408 - Aryl hydrocarbon receptor modulators and uses thereof (2023-04-25),

Title: The Innovative Journey of Inventor Lijun Sun

Introduction: Lijun Sun, a talented inventor based in Harvard, MA (US), has made significant contributions to the field of technology with his groundbreaking inventions and patents.

Latest Patents: Lijun Sun holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: With a background in engineering and a passion for creating solutions to complex problems, Lijun Sun has had a successful career marked by numerous achievements in the world of innovation. His dedication to pushing the boundaries of technology has led to the development of cutting-edge products that have revolutionized their respective industries.

Collaborations: Throughout his career, Lijun Sun has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: Lijun Sun's relentless pursuit of innovation and his commitment to excellence have established him as a prominent figure in the world of inventors. His work continues to inspire future generations of innovators to think outside the box and create solutions that have a lasting impact on society.

Profile summary based on public USPTO records.